
高峰,男,博士,讲师,出生于1989年1月,毕业于中国医学科学院药物研究所药理学专业。主持自治区级项目1项,校级项目1项。目前已发表论文7篇,其中SCI 7篇。主要从事动脉粥样硬化发生发展的分子机制方面的研究。近三年主要教学、科研成果如下:
项目
(1)内蒙古自治区自然科学基金博士项目,AMPK通过泛素-蛋白酶体通路调控巨噬细胞ABCA1表达的分子机制初探,2020BS08010,起止年限2020.1月-2022年12月
论文
(1)Gao F#, Jiao S#, Bi Y Q, et al. The Impact of the SARS-COV-2 Pandemic on the Mental Health and Employment Decisions of Medical Students in North China[J]. Frontiers in Psychiatry, 2021, 12: 825. (co-first)
(2)Gao F, Lv Y W, Long, J, Chen J M, He J M, Ruan X Z, Zhu H B. Butyrate Improves the Metabolic Disorder and Gut Microbiome Dysbiosis in Mice Induced by a High-Fat Diet[J]. Frontiers in Pharmacology, 2019,10:1040.
(3)Gao F#, Qian Y J#, Chen F H, Zhu H B. Comparative analysis of stimulation and binding characteristics of adenosine analogs to AMP-activated protein kinase[J]. Journal of Asian natural products research, 2019, 21(9): 916-927. (co-first)
(4)Gao, F, Chen J, Zhu H. A potential strategy for treating atherosclerosis: improving endothelial function via AMP-activated protein kinase [J]. Science China Life Sciences, 2018, 61(9): 1024-1029.
(5)Li J, Chen B, Zhong L,Gao F, Zhu H, & Wang F. AMP-activated protein kinase agonist N 6-(3-hydroxyphenyl) adenosine protects against fulminant hepatitis by suppressing inflammation and apoptosis[J]. Cell death & disease, 2018, 9(2): 37.
(6)Chao-ran Dong, Jie-mei Chen, Ji-lin Zheng, Yi-ming Liang, Tao Yu, Yu-peng Liu, Feng Gao, Jie Long, Hang-yu Chen, Qian-hui Zhu, Zi-long He, Song-nian Hu, Chuan He, Jian Lin, Yi-da Tang and Haibo Zhu. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease[J]. Clinical Epigenetics, 2020, 12(1): 17.
(7)Jie Long , Jiemei Chen , Qingchun Wang ,Feng Gao , Ming Lian , Peng Zhang 1, Yuejin Yang , Haibo Zhu. NFAT activating protein with ITAM motif 1 (NFAM1) is upregulated on circulating monocytes in coronary artery disease and potentially correlated with monocyte chemotaxis[J]. Atherosclerosis.2020;307:3951.doi:10.1016/j.atherosclerosis.2020.06.001